STI-B120X

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSTI-B120X
Drug Alias Nameanti-RAGE monoclonal antibodies (Sorrento Therapeutics)STI-B120X
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonists
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSorrento Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSorrento Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A